July 24, 2013
FOR IMMEDIATE RELEASE
Contact: Bruce Janele, 800-457-4777
Research by Nobel Laureate Stanley B. Prusiner, MD
TIMONIUM, Maryland, July 24, 2013 - CurePSP is honored to recognize Nobel Laureate and National Medal of Science recipient Stanley B. Prusiner, MD as its first grant recipient under CurePSP's new $15 million Strategic Research Roadmap.
CurePSP is seeking a minimum of $300,000 to fund the development of a new animal model to allow for more precise and rapid testing of large numbers of new drugs that may slow or halt the progression of tau-based neurodegenerative brain diseases. The result could lead to the development of a sensitive and reliable imaging test for various neurological diseases accelerating new drug development and enable early diagnosis of human patients. CurePSP is privileged to have received an initial contribution of $100,000 from Margot and Ross Perot in honor of Margot's sister, Suzanne Birmingham.
Stanley B. Prusiner, MD, is Director of the Institute for Neurodegenerative Diseases and Professor of Neurology at the University of California, San Francisco (UCSF). He received his undergraduate and medical school training at the University of Pennsylvania and his postgraduate clinical training at UCSF. Dr. Prusiner's contributions to scientific research have been internationally recognized and he was awarded the Nobel Prize in Medicine in 1997.
CurePSP is the foremost non-profit organization dedicated to increasing awareness of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and other atypical Parkinsonian disorders; funding research toward treatment, cure and prevention; educating healthcare professionals; and providing support, information and hope for affected persons and their families.